ArticleJournal of thoracic disease2026
Quality of life during the first 3 months after uniportal
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The comparative effect of uniportal video-assisted thoracoscopic surgery (U-VATS) Methods: This prospective observational cohort study assessed QoL with the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-LC29 questionnaires preoperatively and at 2, 4, 8, and 12 weeks after discharge. Longitudinal trajectories were evaluated using linear mixed-effects models in unweighted and inverse probability of treatment weighting (IPTW)-weighted analyses. Results: Among 130 patients, 89 underwent U-VATS and 41 underwent M-VATS. Most symptom and functioning trajectories were similar. Fear of progression showed a group-by-time interaction in both analyses; social functioning differed in the IPTW-weighted analysis, whereas constipation differed in the unweighted analysis. Compared with M-VATS, U-VATS was associated with a shorter operative time (median, 85 Conclusions: Most 3-month QoL trajectories were similar after U-VATS and M-VATS lobectomy. The observed domain-specific differences were exploratory and their clinical importance remains uncertain. U-VATS was associated with more favorable unadjusted perioperative outcomes, but residual confounding precludes causal interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.